This grant is for the purpose of developing the Biologically-derived Medicines on Demand (Bio-MOD) program, aiming to create devices and techniques for producing multiple protein biologics rapidly at the point-of-care. This initiative addresses specific battlefield threats and urgent medical needs. Key objectives include investing in novel, flexible genetic engineering methodologies for microbial, eukaryotic, and cell-free systems to synthesize protein-based therapeutics. Additionally, it seeks to develop portable device platforms for manufacturing diverse biologics with high purity and potency in short timeframes. Ultimately, Bio-MOD will establish a responsive battlefield medical supply, empowering military medics with critical, on-demand treatments in far-forward emergency and in-theater situations.
Opportunity ID: 157214
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | DARPA-BAA-12-37 |
| Funding Opportunity Title: | Biologically-derived Medicines on Demand (Bio-MOD) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant Other Procurement Contract |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 12.910 — Research and Technology Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Mar 21, 2012 |
| Last Updated Date: | May 22, 2012 |
| Original Closing Date for Applications: | Jun 12, 2012 |
| Current Closing Date for Applications: | Jun 21, 2012 |
| Archive Date: | Aug 21, 2012 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | DARPA – Defense Sciences Office |
| Description: | The Bio-MOD program seeks to develop devices and techniques to produce multiple protein biologics in response to specific battlefield threats and medical needs. This will be achieved by investing in (1) novel, flexible methodologies for genetic engineering/modification of microbial strains, eukaryotic strains, and/or cell-free systems to synthesize multiple protein-based therapeutics; and (2) flexible and portable device platforms for manufacturing multiple biologics with high purity, efficacy and potency at the point-of-care, in short timeframes, when the specific need arises. Consequently, Bio-MOD will provide a battlefield medical supply for military medics at the front lines of support that is responsive to far-forward emergency settings and emergent in-theater needs. |
| Link to Additional Information: | DARPA-BAA-12-37 |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
COL Geoffrey Ling
Email:DARPA-BAA-12-37@darpa.mil |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
| The purpose of Modification 1 to DARPA-BAA-12-37 is to change the full proposal due date. See attached Modification 1 to DARPA-BAA-12-37. | May 22, 2012 | |
| May 22, 2012 |
DISPLAYING: Synopsis 2
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | DARPA-BAA-12-37 |
| Funding Opportunity Title: | Biologically-derived Medicines on Demand (Bio-MOD) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant Other Procurement Contract |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 12.910 — Research and Technology Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Mar 21, 2012 |
| Last Updated Date: | May 22, 2012 |
| Original Closing Date for Applications: | Jun 12, 2012 |
| Current Closing Date for Applications: | Jun 21, 2012 |
| Archive Date: | Aug 21, 2012 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | DARPA – Defense Sciences Office |
| Description: | The Bio-MOD program seeks to develop devices and techniques to produce multiple protein biologics in response to specific battlefield threats and medical needs. This will be achieved by investing in (1) novel, flexible methodologies for genetic engineering/modification of microbial strains, eukaryotic strains, and/or cell-free systems to synthesize multiple protein-based therapeutics; and (2) flexible and portable device platforms for manufacturing multiple biologics with high purity, efficacy and potency at the point-of-care, in short timeframes, when the specific need arises. Consequently, Bio-MOD will provide a battlefield medical supply for military medics at the front lines of support that is responsive to far-forward emergency settings and emergent in-theater needs. |
| Link to Additional Information: | DARPA-BAA-12-37 |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
COL Geoffrey Ling
Email:DARPA-BAA-12-37@darpa.mil |
DISPLAYING: Synopsis 1
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | DARPA-BAA-12-37 |
| Funding Opportunity Title: | Biologically-derived Medicines on Demand (Bio-MOD) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant Other Procurement Contract |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 12.910 — Research and Technology Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | May 22, 2012 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Jun 12, 2012 |
| Archive Date: | Aug 13, 2012 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | DARPA – Defense Sciences Office |
| Description: | The Bio-MOD program seeks to develop devices and techniques to produce multiple protein biologics in response to specific battlefield threats and medical needs. This will be achieved by investing in (1) novel, flexible methodologies for genetic engineering/modification of microbial strains, eukaryotic strains, and/or cell-free systems to synthesize multiple protein-based therapeutics; and (2) flexible and portable device platforms for manufacturing multiple biologics with high purity, efficacy and potency at the point-of-care, in short timeframes, when the specific need arises. Consequently, Bio-MOD will provide a battlefield medical supply for military medics at the front lines of support that is responsive to far-forward emergency settings and emergent in-theater needs. |
| Link to Additional Information: | DARPA-BAA-12-37 |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
COL Geoffrey Ling
Email:DARPA-BAA-12-37@darpa.mil |
Related Documents
Folder 157214 Full Announcement-1 -> darpa-baa-12-37.pdf
Folder 157214 Revised Full Announcement-1 -> darpa-baa-12-37 modification 1.pdf
Packages
| Agency Contact Information: | COL Geoffrey Ling Email: DARPA-BAA-12-37@darpa.mil |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 12.910 | PKG00109490 | Mar 21, 2012 | Jun 21, 2012 | View |
Package 1
Mandatory forms
157214 RR_SF424-1.1.pdf
Optional forms
157214 RR_FedNonFedBudget-1.1.pdf
157214 RR_FedNonFed_SubawardBudget-1.2.pdf
157214 RR_OtherProjectInfo-1.1.pdf
157214 RR_Budget-1.1.pdf
157214 RR_KeyPersonExpanded-1.1.pdf
157214 RR_PerformanceSite-1.1.pdf
157214 RR_SubawardBudget-1.2.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
